Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data By: News Direct March 02, 2023 at 05:59 AM EST --News Direct--Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing the data readout from an LPS human challenge trial for POLB 001, the infectious disease focused biopharma company's lead molecule.Skillington says that he "couldn't be happier" with the results, that he says will help "ramp up the discussions" with potential partners.Contact DetailsProactive UK Ltd+44 20 7989 0813uk@proactiveinvestors.comView source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-couldnt-be-happier-with-polb-001-human-challenge-trial-data-264590133 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data By: News Direct March 02, 2023 at 05:59 AM EST --News Direct--Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing the data readout from an LPS human challenge trial for POLB 001, the infectious disease focused biopharma company's lead molecule.Skillington says that he "couldn't be happier" with the results, that he says will help "ramp up the discussions" with potential partners.Contact DetailsProactive UK Ltd+44 20 7989 0813uk@proactiveinvestors.comView source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-couldnt-be-happier-with-polb-001-human-challenge-trial-data-264590133
--News Direct--Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing the data readout from an LPS human challenge trial for POLB 001, the infectious disease focused biopharma company's lead molecule.Skillington says that he "couldn't be happier" with the results, that he says will help "ramp up the discussions" with potential partners.Contact DetailsProactive UK Ltd+44 20 7989 0813uk@proactiveinvestors.comView source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-couldnt-be-happier-with-polb-001-human-challenge-trial-data-264590133